Literature DB >> 22661188

Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6.

Stefan Chłopicki1, Marta Kurdziel, Magdalena Sternak, Małgorzata Szafarz, Joanna Szymura-Oleksiak, Karol Kamiński, Jerzy A Żołądź.   

Abstract

BACKGROUND: Methylnicotinamide (MNA) displays vasoprotective activity, however, the regulation of the activity of nicotinamide-N-methyltransferase (NNMT), is largely unknown. We analyze a possible involvement of IL-6 in the activation of NNMT-MNA pathway during an endurance exercise.
METHODS: FVB, C57Bl/6J IL6(+/+) and C57Bl/6J IL-6(-/-) mice were subjected to the single bout of endurance exercise consisting of 90 min of swimming. Thereafter, exercise-induced changes in NNMT activity in the liver as well as concomitant changes in the concentration of MNA and its further metabolites in plasma were analyzed.
RESULTS: In two strains of mice (FVB and C57Bl/6J IL6(+/+)) 90 min of swimming resulted in approximately 2-3 folds increase in NNMT activity (from 0.14 ± 0.03 to 0.421 ± 0.02 pmol/min/mg, p < 0.05 and from 0.2 ± 0.06 to 0.35 ± 0.07 pmol/min/mg, p < 0.01, respectively) and concomitant increase in the plasma concentration of MNA (from 157 ± 15.06 to 230 ± 16.2 ng/ml, p < 0.01, and from 77.05 ± 14.6 ng/ml to 152.55 ± 58.4 ng/ml; p < 0.01, respectively). However, in C57Bl/6J IL-6(-/-) mice 90 min of swimming did not change liver NNMT activity (from 0.25 ± 0.07 to 0.23 ± 0.06 pmol/min/mg), while MNA concentration in plasma rose approximately two-fold (from 65.3 ± 30.9 ng/ml to 124.8 ± 35.8 ng/ml; p < 0.05).
CONCLUSIONS: We demonstrated for the first time that NNMT - MNA pathway is activated by a single bout of endurance exercise. Interestingly, exercise-induced activation of NNMT in the liver involves IL-6, while the rise in MNA concentration in plasma was partially IL-6-independent. Taking into the consideration the pharmacological activity of MNA, IL-6-dependent and IL-6-independent activation of NNMT, may contribute to the exercise capacity. The physiological role of NNMT in the exercise warrant further studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661188     DOI: 10.1016/s1734-1140(12)70777-6

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  11 in total

1.  N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis.

Authors:  Hui-Chang Bi; Yu-Zhuo Pan; Jing-Xin Qiu; Kristopher W Krausz; Fei Li; Caroline H Johnson; Chang-Tao Jiang; Frank J Gonzalez; Ai-Ming Yu
Journal:  Carcinogenesis       Date:  2014-08-12       Impact factor: 4.944

2.  Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide.

Authors:  Kathrin Schmeisser; Johannes Mansfeld; Doreen Kuhlow; Sandra Weimer; Steffen Priebe; Ines Heiland; Marc Birringer; Marco Groth; Alexandra Segref; Yariv Kanfi; Nathan L Price; Sebastian Schmeisser; Stefan Schuster; Andreas F H Pfeiffer; Reinhard Guthke; Matthias Platzer; Thorsten Hoppe; Haim Y Cohen; Kim Zarse; David A Sinclair; Michael Ristow
Journal:  Nat Chem Biol       Date:  2013-09-29       Impact factor: 15.040

3.  Effects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice.

Authors:  Kamil Przyborowski; Marta Wojewoda; Barbara Sitek; Agnieszka Zakrzewska; Agnieszka Kij; Krystyna Wandzel; Jerzy Andrzej Zoladz; Stefan Chlopicki
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 4.  Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites.

Authors:  Samuel Aj Trammell; Charles Brenner
Journal:  Comput Struct Biotechnol J       Date:  2013-05-27       Impact factor: 7.271

5.  Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.

Authors:  Andrzej Fedorowicz; Łukasz Mateuszuk; Grzegorz Kopec; Tomasz Skórka; Barbara Kutryb-Zając; Agnieszka Zakrzewska; Maria Walczak; Andrzej Jakubowski; Magdalena Łomnicka; Ewa Słomińska; Stefan Chlopicki
Journal:  Respir Res       Date:  2016-08-31

Review 6.  Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?

Authors:  Lisa J Hill; Adrian C Williams
Journal:  Int J Tryptophan Res       Date:  2017-05-03

7.  N1-methylnicotinamide is a signalling molecule produced in skeletal muscle coordinating energy metabolism.

Authors:  Kristoffer Ström; David Morales-Alamo; Filip Ottosson; Anna Edlund; Line Hjort; Sine W Jörgensen; Peter Almgren; Yuedan Zhou; Marcos Martin-Rincon; Carl Ekman; Alberto Pérez-López; Ola Ekström; Ismael Perez-Suarez; Markus Mattiasson; Pedro de Pablos-Velasco; Nikolay Oskolkov; Emma Ahlqvist; Nils Wierup; Lena Eliasson; Allan Vaag; Leif Groop; Karin G Stenkula; Céline Fernandez; Jose A L Calbet; Hans-Christer Holmberg; Ola Hansson
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

8.  Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1.

Authors:  Zhenyu You; Yang Liu; Xuefei Liu
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

9.  The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease.

Authors:  Rina Takahashi; Takeshi Kanda; Motoaki Komatsu; Tomoaki Itoh; Hitoshi Minakuchi; Hidenori Urai; Tomohiro Kuroita; Shuhei Shigaki; Tasuku Tsukamoto; Naoko Higuchi; Minoru Ikeda; Risa Yamanaka; Norito Yoshimura; Takashi Ono; Hideo Yukioka; Kazuhiro Hasegawa; Hirobumi Tokuyama; Shu Wakino; Hiroshi Itoh
Journal:  Sci Rep       Date:  2022-04-16       Impact factor: 4.996

10.  Running performance at high running velocities is impaired but V'O(₂max) and peripheral endothelial function are preserved in IL-6⁻/⁻ mice.

Authors:  Marta Wojewoda; Katarzyna Kmiecik; Renée Ventura-Clapier; Dominique Fortin; Marta Onopiuk; Justyna Jakubczyk; Barbara Sitek; Andrzej Fedorowicz; Joanna Majerczak; Karol Kaminski; Stefan Chlopicki; Jerzy Andrzej Zoladz
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.